title: Lymphocyte subsets in alcoholic liver disease.
abstract: OBJECTIVE
  To compare lymphocyte subsets between healthy controls and alcoholics with liver disease.
  
  
  METHODS
  The patient cohort for this study included individuals who were suspected to have alcoholic liver disease (ALD) and who had undergone liver biopsy (for disease grading and staging, doubts about diagnosis, or concurrent liver disease; n = 56). Normal controls included patients who were admitted for elective cholecystectomy due to non-complicated gallstones (n = 27). Formalin-fixed, paraffin-embedded liver biopsy specimens were sectioned and stained with hematoxylin and eosin and Perls' Prussian blue. The non-alcoholic steatohepatitis score was used to assess markers of ALD. Lymphocyte population subsets were determined by flow cytometry. T lymphocytes were identified (CD3(+)), and then further subdivided into CD4(+) or CD8(+) populations. B lymphocytes (CD19(+)) and natural killer (NK) cell numbers were also measured. In addition to assessing lymphocyte subpopulation differences between ALD patients and controls, we also compared subsets of alcoholic patients without cirrhosis or abstinent cirrhotic patients to normal controls.
  
  
  RESULTS
  The patient cohort primarily consisted of older men. Active alcoholism was present in 66.1%. Reported average daily alcohol intake was 164.9 g and the average lifetime cumulative intake was 2211.6 kg. Cirrhosis was present in 39.3% of the patients and 66.1% had significant fibrosis (perisinusoidal and portal/periportal fibrosis, bridging fibrosis, or cirrhosis) in their liver samples. The average Mayo end-stage liver disease score was 7.6. No hereditary hemochromatosis genotypes were found. ALD patients (n = 56) presented with significant lymphopenia (1.5 × 10(9)/L ± 0.5 × 10(9)/L vs 2.1 × 10(9)/L ± 0.5 × 10(9)/L, P < 0.0001), due to a decrease in all lymphocyte subpopulations, except for NK lymphocytes: CD3(+) (1013.0 ± 406.2/mm(3) vs 1523.0 ± 364.6/mm(3), P < 0.0001), CD4(+) (713.5 ± 284.7/mm(3) vs 992.4 ± 274.7/mm(3), P < 0.0001), CD8(+) (262.3 ± 140.4/mm(3) vs 478.9 ± 164.6/mm(3), P < 0.0001), and CD19(+) (120.6 ± 76.1/mm(3) vs 264.6 ± 88.0/mm(3), P < 0.0001). CD8(+) lymphocytes suffered the greatest reduction, as evidenced by an increase in the CD4(+)/CD8(+) ratio (3.1 ± 1.3 vs 2.3 ± 0.9, P = 0.013). This ratio was associated with the stage of fibrosis on liver biopsy (r s = 0.342, P = 0.01) and with Child-Pugh score (r s = 0.482, P = 0.02). The number of CD8(+) lymphocytes also had a positive association with serum ferritin levels (r s = 0.345, P = 0.009). Considering only patients with active alcoholism but not cirrhosis (n = 27), we found similar reductions in total lymphocyte counts (1.8 × 10(9)/L ± 0.3 × 10(9)/L vs 2.1 × 10(9)/L ± 0.5 × 10(9)/L, P = 0.018), and in populations of CD3(+) (1164.7 ± 376.6/mm(3) vs 1523.0 ± 364.6/mm(3), P = 0.001), CD4(+) (759.8 ± 265.0/mm(3) vs 992.4 ± 274.7/mm(3), P = 0.003), CD8(+) (330.9 ± 156.3/mm(3) vs 478.9 ± 164.6/mm(3), P = 0.002), and CD19(+) (108.8 ± 64.2/mm(3) vs 264.6 ± 88.0/mm(3), P < 0.0001). In these patients, the CD4(+)/CD8(+) ratio and the number of NK lymphocytes was not significantly different, compared to controls. Comparing patients with liver cirrhosis but without active alcohol consumption (n = 11), we also found significant lymphopenia (1.3 × 10(9)/L ± 0.6 × 10(9)/L vs 2.1 × 10(9)/L ± 0.5 × 10(9)/L, P < 0.0001) and decreases in populations of CD3(+) (945.5 ± 547.4/mm(3) vs 1523.0 ± 364.6/mm(3), P = 0.003), CD4(+) (745.2 ± 389.0/mm(3) vs 992.4 ± 274.7/mm(3), P = 0.032), CD8(+) (233.9 ± 120.0/mm(3) vs 478.9 ± 164.6/mm(3), P < 0.0001), and CD19(+) (150.8 ± 76.1/mm(3) vs 264.6 ± 88.0/mm(3), P = 0.001). The NK lymphocyte count was not significantly different, but, in this group, there was a significant increase in the CD4(+)/CD8(+) ratio (3.5 ± 1.3 vs 2.3 ± 0.9, P = 0.01).
  
  
  CONCLUSIONS
  All patient subsets presented with decreased lymphocyte counts, but only patients with advanced fibrosis presented with a significant increase in the CD4(+)/CD8(+) ratio.
authors: Luís Costa Matos, Armando Carvalho, Faculty of Medicine of the University of Coimbra, 3004-504 Coimbra, Portugal.
authors: Luís Costa
authors: LC
authors: Matos
authors: Paulo
authors: P
authors: Batista
authors: Nuno
authors: N
authors: Monteiro
authors: João
authors: J
authors: Ribeiro
authors: Maria A
authors: MA
authors: Cipriano
authors: Pedro
authors: P
authors: Henriques
authors: Fernando
authors: F
authors: Girão
authors: Armando
authors: A
authors: Carvalho
keywords: Alcoholic liver disease; Alcoholism; Flow cytometry; HFE gene; Liver biopsy; Liver fibrosis; Lymphocyte subsets
references: Alcohol Clin Exp Res. 2000 Apr;24(4):519-27
references: 10798589
references: J Clin Lab Immunol. 1987 Aug;23(4):161-7
references: 2959783
references: Alcohol. 2011 Aug;45(5):507-14
references: 21624786
references: Biochim Biophys Acta. 2009 Jul;1790(7):663-70
references: 18848602
references: Hepatology. 2008 Sep;48(3):963-77
references: 18726940
references: Gastroenterology. 2004 Sep;127(3):870-82
references: 15362042
references: Clin Exp Immunol. 1997 Apr;108(1):144-50
references: 9097923
references: Gastroenterology. 2008 Jan;134(1):248-58
references: 18166357
references: Tissue Antigens. 2004 Jul;64(1):25-34
references: 15191520
references: Pancreatology. 2007;7(2-3):115-23
references: 17592223
references: Hum Immunol. 2001 May;62(5):488-99
references: 11334672
references: Nat Genet. 1996 Aug;13(4):399-408
references: 8696333
references: Addict Biol. 2000 Apr 1;5(2):141-51
references: 20575828
references: Gastroenterology. 2006 Feb;130(2):435-52
references: 16472598
references: Alcohol. 2003 Jun;30(2):137-44
references: 12957298
references: Alcohol. 2008 Aug;42(5):349-61
references: 18504085
references: Alcohol Clin Exp Res. 1996 Dec;20(9):1564-8
references: 8986204
references: Semin Liver Dis. 1986 Aug;6(3):221-32
references: 3022386
references: Scand J Gastroenterol. 1991 Mar;26(3):295-301
references: 1830163
references: Gut. 1981 Feb;22(2):149-52
references: 7215946
references: Hepatology. 2005 Jun;41(6):1313-21
references: 15915461
references: Hepatol Res. 2011 Jan;41(1):22-9
references: 21108703
references: Hepatology. 1994 Dec;20(6):1465-71
references: 7982646
references: Blood Cells Mol Dis. 2006 Jul-Aug;37(1):33-9
references: 16762569
references: Gastroenterology. 2008 Jan;134(1):351-3
references: 18166364
references: Hepatol Int. 2010 Oct 21;4(4):659-72
references: 21286336
references: J Clin Lab Immunol. 1984 Jan;13(1):21-4
references: 6609235
references: Int J Clin Lab Res. 1995;25(3):153-6
references: 8562979
references: J Dig Dis. 2011 Feb;12(1):17-24
references: 21091934
references: Semin Liver Dis. 1995 Aug;15(3):283-300
references: 7491507
references: Am J Physiol. 1998 Oct;275(4):G605-11
references: 9756487
references: Clin Exp Immunol. 1996 Feb;103(2):304-10
references: 8565316
references: Ann Hematol. 2010 Aug;89(8):767-73
references: 20107990
references: Alcohol Clin Exp Res. 1995 Jun;19(3):555-63
references: 7573774
references: Semin Liver Dis. 1988 Feb;8(1):12-25
references: 3283941
references: Immune Netw. 2010 Dec;10(6):181-7
references: 21286378
references: Eur J Clin Invest. 2001 Jan;31(1):45-53
references: 11168438
references: Lancet. 2002 Nov 2;360(9343):1347-60
references: 12423980
references: J Clin Immunol. 1991 Sep;11(5):246-53
references: 1839029
references: Semin Liver Dis. 2001 Aug;21(3):427-36
references: 11586470
references: Am J Gastroenterol. 1998 Nov;93(11):2022-36
references: 9820369
references: J Gastroenterol Hepatol. 2008 Mar;23 Suppl 1:S112-8
references: 18336653
references: Clin Exp Immunol. 2010 Mar;159(3):363-71
references: 20015273
references: Clin Exp Immunol. 1997 Mar;107(3):548-54
references: 9067531
references: Trends Immunol. 2009 Jan;30(1):13-22
references: 19059005
references: PLoS One. 2011;6(6):e20635
references: 21673994
references: Scand J Immunol. 1994 May;39(5):426-32
references: 8191217
references: World J Gastroenterol. 2002 Dec;8(6):961-5
references: 12439906
references: Am J Med. 1990 Aug;89(2):129-33
references: 2382661
references: Alcohol Res Health. 2003;27(4):307-16
references: 15540802
references: Hepatology. 1997 May;25(5):1096-100
references: 9141423
references: Am J Physiol Gastrointest Liver Physiol. 2011 Sep;301(3):G425-34
references: 21659620
references: Clin Liver Dis. 2005 Feb;9(1):37-53
references: 15763228
references: Gastroenterol Clin Biol. 1984 Dec;8(12):915-9
references: 6519399